National Health (Listed drugs on F1 or F2) Amendment Determination 2012 (No. 7) (No. PB 81 of 2012) (Cth)
PB 81 of 2012
National Health (Listed drugs on F1 or F2) Amendment Determination 2012 (No. 7)
National Health Act 1953
I, ADRIANA PLATONA, Assistant Secretary, Pharmaceutical Evaluation Branch, Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the
Minister for Health, make this determination under subsection 85AB(1) of the National Health Act 1953.
Dated 25 September 2012
ADRIANA PLATONA
Assistant Secretary
Pharmaceutical Evaluation Branch
Pharmaceutical Benefits Division
Department of Health and Ageing
Part 1 Preliminary
Name of Determination
(1) This Determination is the National Health (Listed drugs on F1 or F2) Amendment Determination 2012 (No. 7).
(2) This Determination may also be cited as PB 81 of 2012.
Commencement
This Determination commences on 1 October 2012.
Amendment of National Health (Listed drugs on F1 or F2) Determination 2010
Schedule 1 amends the National Health (Listed drugs on F1 or F2) Determination 2010 (PB 93 of 2010).
Schedule 1 Amendments
(Section 3)
[1] Schedule 1, after item dealing with Carbomer 974
Insert
Carbomer with Triglyceride Lipids
[2] Schedule 1, after item dealing with Homatropine
Insert
Human Menopausal Gonadotrophin
[3] Schedule 1, after item dealing with Pancrelipase
Insert
Pazopanib
[4] Schedule 2, after item dealing with Risedronic acid and Calcium
Insert
Risedronic acid and calcium with colecalciferol
Note
1. All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003. See
0
0
0